S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
NASDAQ:THRX

Theseus Pharmaceuticals News Headlines

$9.96
+0.05 (+0.50%)
(As of 01/21/2022 12:00 AM ET)
Add
Compare
Today's Range
$9.46
$10.28
50-Day Range
$8.98
$20.09
52-Week Range
$8.65
$24.54
Volume
217,105 shs
Average Volume
154,307 shs
Market Capitalization
$385.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
Get Theseus Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for THRX and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Theseus Pharmaceuticals Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

THRX
News Sentiment

0.70

0.39

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

THRX Articles
This Week

8

1

THRX Articles
Average Week



Theseus Pharmaceuticals (NASDAQ:THRX) News Headlines Today

SourceHeadline
marketbeat.com logoTheseus Pharmaceuticals (NASDAQ:THRX) Downgraded by Zacks Investment Research to "Sell"
marketbeat.com - January 18 at 10:17 AM
MarketBeat logoTheseus Pharmaceuticals Inc (NASDAQ:THRX) Director Carl L. Gordon Purchases 111,896 Shares
americanbankingnews.com - January 21 at 9:22 PM
insidertrades.com logoInsider Buying: Theseus Pharmaceuticals Inc (NASDAQ:THRX) Director Buys 11,521 Shares of Stock
insidertrades.com - January 21 at 9:22 PM
nasdaq.com logoTop Stocks To Invest In Right Now? 5 Health Care Stocks To Watch
nasdaq.com - January 18 at 3:24 PM
nasdaq.com logoTheseus Pharmaceuticals Inc Shares Close the Day 23.2% Higher - Daily Wrap
nasdaq.com - January 15 at 11:52 AM
seekingalpha.com logoTheseus Pharma gains after insider purchase
seekingalpha.com - January 14 at 3:22 PM
MarketBeat logoTheseus Pharmaceuticals Inc (NASDAQ:THRX) Director Buys $163,327.60 in Stock
americanbankingnews.com - January 13 at 9:34 PM
insidertrades.com logoInsider Buying: Theseus Pharmaceuticals Inc (NASDAQ:THRX) Director Purchases 8,500 Shares of Stock
insidertrades.com - January 13 at 9:34 PM
benzinga.com logoTheseus Pharmaceuticals Announces First Patient Treated With THE-630 In Phase 1/2 Study In Patients with Advanced Gastrointestinal Stromal Tumors
benzinga.com - January 11 at 3:26 AM
nasdaq.com logoHere's What Theseus Pharmaceuticals, Inc.'s (NASDAQ:THRX) Shareholder Ownership Structure Looks Like
nasdaq.com - January 7 at 8:53 PM
finance.yahoo.com logoCompanies Like Theseus Pharmaceuticals (NASDAQ:THRX) Are In A Position To Invest In Growth
finance.yahoo.com - January 7 at 3:41 PM
barrons.com logoTheseus Pharmaceuticals Inc.
barrons.com - December 17 at 12:33 AM
msn.com logo33 Stocks Moving In Monday's Mid-Day Session
msn.com - November 29 at 1:45 PM
finance.yahoo.com logoTheseus Pharmaceuticals to Participate Virtually in Jefferies London Healthcare Conference
finance.yahoo.com - November 15 at 4:37 PM
finance.yahoo.com logoTheseus Pharmaceuticals Announces Business and Program Highlights and Reports Third Quarter 2021 Financial Results
finance.yahoo.com - November 15 at 4:37 PM
finance.yahoo.com logoAnalysts See Huge Upside In This Newly Listed Biopharma Stock
finance.yahoo.com - November 4 at 8:21 AM
Get Theseus Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for THRX and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 1/21/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.